News and Analysis

Viridian Therapeutics’ Lumvoa is approved for treating both the chronic and active phases of thyroid eye disease. This drug will offer patients an alternative to

Prominent activists with the “Make America Healthy Again” (MAHA) movement are raging and saying they feel betrayed after the Supreme Court sided with pesticide maker

Insilico Medicine will partner with SK Biopharmaceuticals to discover new artificial intelligence (AI)-based drug candidates for disorders affecting the neuroimmune area of the central nervous

Sen. Bill Cassidy (R-La.) in a Sunday inteview sought to explain his controversial vote to confirm Health and Human Services (HHS) Secretary Robert F. Kennedy